Hinge Health, Inc. Q3 2026 Earnings Recap

Hinge Health reported 52% revenue growth and improved margins in Q3, while the stock rose 1.2%—a relatively muted reaction. The transcript highlights strong current profitability and early progress in new care programs, but provides limited detail here on the updated outlook.

Key Takeaways

• Revenue was $235 million, up 52% year over year; last-12-month calculated billings increased 54% to $960 million.
• Gross margin reached 88%, up about 480 basis points year over year. Operating income was $77 million, a 33% margin, up about 1,300 basis points.
• Free cash flow, excluding one-time acquisition-related payments, was $120 million, or a 51% margin.
• Early-access Migraine Care results included a 23% reduction in monthly migraine days; attacks were about five hours shorter on average, and roughly two-thirds of surveyed members improved their HIT-6 score.
• The company described its planned GI Care offering and AI-enabled features, but the provided transcript ends before the full program details and updated financial guidance.